94 related articles for article (PubMed ID: 2764524)
1. Antitumor effect of some rhodium(I) derivatives on MCa mammary carcinoma.
Sava G; Pacor S; Ceschia V; Zassinovich G; Mestroni G
Anticancer Res; 1989; 9(3):787-90. PubMed ID: 2764524
[TBL] [Abstract][Full Text] [Related]
2. Effects of two pyridinalalkyliminerhodium(I) complexes in mice bearing MCa mammary carcinoma.
Sava G; Zorzet S; Pacor S; Mestroni G; Zassinovich G
Cancer Chemother Pharmacol; 1989; 24(5):302-6. PubMed ID: 2758559
[TBL] [Abstract][Full Text] [Related]
3. Effects of some ruthenium chelates on MCa mammary carcinoma and on TLX5 lymphoma in mice.
Bregant F; Pacor S; Ghosh S; Chattopadhyay SK; Sava G
Anticancer Res; 1993; 13(4):1011-7. PubMed ID: 8352519
[TBL] [Abstract][Full Text] [Related]
4. Antineoplastic effects of egg-white lysozyme in mice bearing solid metastasizing tumors.
Sava G; Perissin L; Zorzet S; Callerio C
Anticancer Res; 1986; 6(2):183-6. PubMed ID: 3707053
[TBL] [Abstract][Full Text] [Related]
5. Antineoplastic activity of planar rhodium(I) complexes in mice bearing Lewis lung carcinoma and P388 leukemia.
Sava G; Zorzet S; Mestroni G; Zassinovich G
Anticancer Res; 1985; 5(3):249-52. PubMed ID: 4015038
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of the antineoplastic action of lysozyme: evidence for host mediated effects.
Sava G; Ceschia V; Pacor S
Anticancer Res; 1989; 9(4):1175-80. PubMed ID: 2817798
[TBL] [Abstract][Full Text] [Related]
7. Isolation of a murine metastatic cell line and preliminary test of sensitivity to the anti-metastasis agent NAMI-A.
Pacor S; Vadori M; Vita F; Bacac M; Soranzo MR; Zabucchi G; Sava G
Anticancer Res; 2001; 21(4A):2523-30. PubMed ID: 11724317
[TBL] [Abstract][Full Text] [Related]
8. Tranilast inhibits the growth and metastasis of mammary carcinoma.
Chakrabarti R; Subramaniam V; Abdalla S; Jothy S; Prud'homme GJ
Anticancer Drugs; 2009 Jun; 20(5):334-45. PubMed ID: 19322072
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effect of water-soluble derivative of propolis and its polyphenolic compounds on tumor growth and metastasizing ability: a possible mode of antitumor action.
Orsolić N; Sver L; Terzić S; Tadić Z; Basić I
Nutr Cancer; 2003; 47(2):156-63. PubMed ID: 15087268
[TBL] [Abstract][Full Text] [Related]
10. Increase of tumour infiltrating lymphocytes in mice treated with antimetastatic doses of NAMI-A.
Magnarin M; Bergamo A; Carotenuto ME; Zorzet S; Sava G
Anticancer Res; 2000; 20(5A):2939-44. PubMed ID: 11062704
[TBL] [Abstract][Full Text] [Related]
11. Dual Action of NAMI-A in inhibition of solid tumor metastasis: selective targeting of metastatic cells and binding to collagen.
Sava G; Zorzet S; Turrin C; Vita F; Soranzo M; Zabucchi G; Cocchietto M; Bergamo A; DiGiovine S; Pezzoni G; Sartor L; Garbisa S
Clin Cancer Res; 2003 May; 9(5):1898-905. PubMed ID: 12738748
[TBL] [Abstract][Full Text] [Related]
12. Antitumor, hematostimulative and radioprotective action of water-soluble derivative of propolis (WSDP).
Orsolić N; Basić I
Biomed Pharmacother; 2005 Dec; 59(10):561-70. PubMed ID: 16202559
[TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo evaluation of ruthenium(II)-arene PTA complexes.
Scolaro C; Bergamo A; Brescacin L; Delfino R; Cocchietto M; Laurenczy G; Geldbach TJ; Sava G; Dyson PJ
J Med Chem; 2005 Jun; 48(12):4161-71. PubMed ID: 15943488
[TBL] [Abstract][Full Text] [Related]
14. Ruthenium-based NAMI-A type complexes with in vivo selective metastasis reduction and in vitro invasion inhibition unrelated to cell cytotoxicity.
Bergamo A; Gava B; Alessio E; Mestroni G; Serli B; Cocchietto M; Zorzet S; Sava G
Int J Oncol; 2002 Dec; 21(6):1331-8. PubMed ID: 12429985
[TBL] [Abstract][Full Text] [Related]
15. Antineoplastic action of egg-white lysozyme on the growth of MCa mammary carcinoma and TLX5 lymphoma in the CBA mouse.
Sava G; Ceschia V; Pacor S; Zorzet S; Perissin L
Methods Find Exp Clin Pharmacol; 1989 Nov; 11(11):683-9. PubMed ID: 2622298
[TBL] [Abstract][Full Text] [Related]
16. Potential of the aminosterol, squalamine in combination therapy in the rat 13,762 mammary carcinoma and the murine Lewis lung carcinoma.
Teicher BA; Williams JI; Takeuchi H; Ara G; Herbst RS; Buxton D
Anticancer Res; 1998; 18(4A):2567-73. PubMed ID: 9703911
[TBL] [Abstract][Full Text] [Related]
17. Antimetastatic action and lymphocyte activation by the modified lysozyme mPEG-Lyso in mice with MCa mammary carcinoma.
Pacor S; Giacomello E; Bergamo A; Clerici K; Zacchigna M; Boccu E; Sava G
Anticancer Res; 1996; 16(5A):2559-64. PubMed ID: 8917351
[TBL] [Abstract][Full Text] [Related]
18. The antitumor effect of postoperative treatment with genistein alone or combined with cyclophosphamide in mice bearing transplantable tumors.
Wietrzyk J; Opolski A; Madej J; Radzikowski C
Acta Pol Pharm; 2000 Nov; 57 Suppl():5-8. PubMed ID: 11293263
[TBL] [Abstract][Full Text] [Related]
19. [Inhibitory effect of UFT on postoperative lung metastasis of mammary adenocarcinoma in SHR rats].
Komatsumoto M; Li S; Hamada J; Takeichi N; Hosokawa M; Okayasu T; Tanabe T; Kobayashi H
Gan To Kagaku Ryoho; 1988 May; 15(5):1739-45. PubMed ID: 3130810
[TBL] [Abstract][Full Text] [Related]
20. Role of organ-associated NK cells in decreased formation of experimental metastases in lung and liver.
Wiltrout RH; Herberman RB; Zhang SR; Chirigos MA; Ortaldo JR; Green KM; Talmadge JE
J Immunol; 1985 Jun; 134(6):4267-75. PubMed ID: 3989307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
